Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Medicine (Baltimore). 2022 Sep 9;101(36):e30184. doi: 10.1097/MD.0000000000030184.
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that imposes a huge economic burden on global public health. And the gut-liver axis theory supports the therapeutic role of intestinal flora in the development and progression of NAFLD. To this end, we designed bioinformatics study on the relationship between intestinal flora disorder and NAFLD, to explore the possible molecular mechanism of intestinal flora interfering with NAFLD.
Differentially expressed genes for NAFLD were obtained from the GEO database. And the disease genes for NAFLD and intestinal flora disorder were obtained from the disease databases. The protein-protein interaction network was established by string 11.0 database and visualized by Cytoscape 3.7.2 software. Cytoscape plug-in MCODE and cytoHubba were used to screen the potential genes of intestinal flora disorder and NAFLD, to obtain potential targets for intestinal flora to interfere in the occurrence and process of NAFLD. Enrichment analysis of potential targets was carried out using R 4.0.2 software.
The results showed that 7 targets might be the key genes for intestinal flora to interfere with NAFLD. CCL2, IL6, IL1B, and FOS are mainly related to the occurrence and development mechanism of NAFLD, while PTGS2, SPINK1, and C5AR1 are mainly related to the intervention of intestinal flora in the occurrence and development of NAFLD. The gene function is mainly reflected in basic biological processes, including the regulation of metabolic process, epithelial development, and immune influence. The pathway is mainly related to signal transduction, immune regulation, and physiological metabolism. The TNF signaling pathway, AGE-RAGE signaling pathway in diabetic activity, and NF-Kappa B signaling pathways are important pathways for intestinal flora to interfere with NAFLD. According to the analysis results, there is a certain correlation between intestinal flora disorder and NAFLD.
It is speculated that the mechanism by which intestinal flora may interfere with the occurrence and development of NAFLD is mainly related to inflammatory response and insulin resistance. Nevertheless, further research is needed to explore the specific molecular mechanisms.
非酒精性脂肪性肝病(NAFLD)是一种常见的慢性肝病,给全球公共卫生带来了巨大的经济负担。肠道-肝脏轴理论支持肠道菌群在 NAFLD 的发生和发展中发挥治疗作用。为此,我们设计了肠道菌群紊乱与 NAFLD 关系的生物信息学研究,以探讨肠道菌群干扰 NAFLD 的可能分子机制。
从 GEO 数据库中获得 NAFLD 的差异表达基因。从疾病数据库中获得 NAFLD 和肠道菌群紊乱的疾病基因。使用 string 11.0 数据库建立蛋白质-蛋白质相互作用网络,并使用 Cytoscape 3.7.2 软件可视化。使用 Cytoscape 插件 MCODE 和 cytoHubba 筛选肠道菌群紊乱和 NAFLD 的潜在基因,获得肠道菌群干扰 NAFLD 发生和进程的潜在靶点。使用 R 4.0.2 软件对潜在靶点进行富集分析。
结果表明,7 个靶标可能是肠道菌群干扰 NAFLD 的关键基因。CCL2、IL6、IL1B 和 FOS 主要与 NAFLD 的发生和发展机制有关,而 PTGS2、SPINK1 和 C5AR1 主要与肠道菌群对 NAFLD 发生和发展的干预有关。基因功能主要体现在基本的生物过程中,包括代谢过程、上皮发育和免疫影响的调节。途径主要与信号转导、免疫调节和生理代谢有关。TNF 信号通路、AGE-RAGE 信号通路在糖尿病活性中、NF-Kappa B 信号通路是肠道菌群干扰 NAFLD 的重要通路。根据分析结果,肠道菌群紊乱与 NAFLD 之间存在一定的相关性。
推测肠道菌群可能通过炎症反应和胰岛素抵抗等机制干扰 NAFLD 的发生和发展。然而,需要进一步研究来探索具体的分子机制。